Lifeboat Foundation

Researchers at Tel Aviv University, led by Prof. Yaniv Assaf of the School of Neurobiology, Biochemistry and Biophysics and the Sagol School of Neuroscience and Prof. Yossi Yovel of the School of Zoology, the Sagol School of Neuroscience, and the Steinhardt Museum of Natural History, conducted a first-of-its-kind study designed to investigate brain connectivity in 130 mammalian species. The intriguing results, contradicting widespread conjectures, revealed that brain connectivity levels are equal in all mammals, including humans.

“We discovered that brain connectivity —namely the efficiency of information transfer through the neural network —does not depend on either the size or structure of any specific brain,” says Prof. Assaf. “In other words, the brains of all mammals, from tiny mice through humans to large bulls and dolphins, exhibit equal connectivity, and information travels with the same efficiency within them. We also found that the brain preserves this balance via a special compensation mechanism: when connectivity between the hemispheres is high, connectivity within each hemisphere is relatively low, and vice versa.”

Participants included researchers from the Kimron Veterinary Institute in Beit Dagan, the School of Computer Science at TAU and the Technion’s Faculty of Medicine. The paper was published in Nature Neuroscience on June 8.

The pandemic has accelerated demand for robots and automation. Robots have been regulated to marketing jobs, receptionist duties, and companionship for the elderly. But they’re really starting to come into their own and have practical use. Let’s take a look at how.

Supermarkets started to adopt robots to free up employees who previously spent time taking inventory to focus on disinfecting and sanitizing surfaces and processing deliveries to keep shelves stocked.

These retailers insist the robots are augmenting the work of employees, not replacing them. But as panic buying stops and sales decline in the recession, companies may no longer have a need for these workers.

DNA usually forms the classic double helix shape discovered in 1953—two strands wound around each other. Several other structures have been formed in test tubes, but this does not necessarily mean they form within living cells.

Quadruple helix structures, called DNA G-quadruplexes (G4s), have previously been detected in cells. However, the technique used required either killing the cells or using high concentrations of chemical probes to visualise G4 formation, so their actual presence within living cells under normal conditions has not been tracked, until now.

A research team from the University of Cambridge, Imperial College London and Leeds University have invented a fluorescent marker that is able to attach to G4s in living human cells, allowing them to see for the first time how the structure forms and what role it plays in cells.

Imagine if this very cheap thing could treat coronavirus 🤔

That would put a wrench in profiteers plans:

Green coffee bean extract is a popular weight loss and health supplement, but does it work, and is it safe?

Continue reading “Does green coffee bean extract work? A detailed review” »

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected.

Circa 2018

Back in July 2018, researchers at Purdue University created the world’s fastest-spinning object, which whipped around at 60 billion rpm – and now that seems like the teacup ride at Disneyland. The same team has now broken its own record using the same technique, creating a new nano-scale rotor that spins five times faster.

Like the earlier version, the whirling object in question is a dumbbell-shaped silica nanoparticle suspended in a vacuum. When it’s set spinning, this new model hit the blistering speed of over 300 billion rpm. For comparison, dentist drills are known to get up to about 500,000 rpm, while the fastest pulsar – which is the speediest-spinning known natural object – turns at a leisurely 43,000 rpm.

Continue reading “Fastest spinning object in the world hits 300 billion rpm” »

Early results in The Lancet on Oxford coronavirus vaccine clinical made by AstraZeneca suggest the COVID-19 vaccine is safe and induces antibodies and T cell response.

The Israeli startup CorNeat Vision has received approval to conduct clinical trials of a synthetic cornea that bio-integrates with the human eye.

The Health Ministry-approved trial of the CorNeat KPro will be run at Beilinson Hospital in Petach Tikva on 10 patients suffering from corneal blindness who are either not candidates for or have experienced one or more failed cornea transplants, the company announced last week.

Yesterday, Regeneron Pharmaceuticals, with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), announced it was launching Phase III trials of REGN-COV2, the company’s two-antibody cocktail for the treatment and prevention of COVID-19. Today, it announced that it had received a $450 million contract to manufacture and supply the antibody cocktail as part of Operation Warp Speed from the Biomedical Advanced Research and Development Authority (BARDA).

BARDA is part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. The contract was also with the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.

A Phase I trial in 30 hospitalized and non-hospitalized patients with COVID-19 received a positive review from the Independent Data Monitoring Committee.

Continue reading “Regeneron Receives $450 Million BARDA Contract for COVID-19 Antibody Cocktail” »